Emerging Targets for Modulation of Immune Response and Inflammation in Stroke

[1]  M. Rovaris,et al.  Myelin Basic Protein in Oligodendrocyte-Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study , 2023, International journal of molecular sciences.

[2]  I. Biose,et al.  Promising Cerebral Blood Flow Enhancers in Acute Ischemic Stroke , 2022, Translational Stroke Research.

[3]  T. G. Singh,et al.  Mechanistic insights on impact of Adenosine monophosphate-activated protein kinase (AMPK) mediated signalling pathways on cerebral ischemic injury , 2022, Neuroscience Research.

[4]  H. Khan,et al.  Adenosine as a Key Mediator of Neuronal Survival in Cerebral Ischemic Injury , 2022, Neurochemical Research.

[5]  Noah Goshi,et al.  Primary Cortical Cell Tri-Culture-Based Screening of Neuroinflammatory Response in Toll-like Receptor Activation , 2022, Biomedicines.

[6]  Yikai Liu,et al.  Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes , 2022, Frontiers in Endocrinology.

[7]  T. G. Singh,et al.  Intervention of neuroinflammation in the traumatic brain injury trajectory: In vivo and clinical approaches. , 2022, International immunopharmacology.

[8]  T. G. Singh,et al.  Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke , 2022, Neurochemical Research.

[9]  R. Kream,et al.  Reassessment of the blood-brain barrier: a potential target for viral entry into the immune-privileged brain. , 2022, Germs.

[10]  T. G. Singh,et al.  Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury , 2022, Inflammation Research.

[11]  T. G. Singh,et al.  Mechanistic Insight on Autophagy Modulated Molecular Pathways in Cerebral Ischemic Injury: From Preclinical to Clinical Perspective , 2022, Neurochemical Research.

[12]  T. G. Singh,et al.  Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative Diseases , 2022, Neurochemical Research.

[13]  G. Giambartolomei,et al.  Microglia at the Crossroads of Pathogen-Induced Neuroinflammation , 2022, ASN neuro.

[14]  A. Abdelhadi,et al.  Therapeutic potential of nitric oxide synthase inhibitor from natural sources for the treatment of ischemic stroke , 2021, Saudi journal of biological sciences.

[15]  G. Guney Eskiler,et al.  The relationship between the efficacy of talazoparib and the functional toll-like receptors 3 and 9 in triple negative breast cancer. , 2021, Molecular immunology.

[16]  Daishi Tian,et al.  Sphingosine-1-Phosphate Signaling in Ischemic Stroke: From Bench to Bedside and Beyond , 2021, Frontiers in Cellular Neuroscience.

[17]  T. G. Singh,et al.  Neuropeptides: Potential neuroprotective agents in ischemic injury. , 2021, Life sciences.

[18]  K. Fitzgerald,et al.  Apoptosis, Pyroptosis, and Necroptosis-Oh My! The Many Ways a Cell Can Die. , 2021, Journal of molecular biology.

[19]  E. Shevach,et al.  IL-35 promotes CD4+Foxp3+ Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms , 2021, JCI insight.

[20]  Minghua Wu,et al.  Pattern recognition receptors in health and diseases , 2021, Signal Transduction and Targeted Therapy.

[21]  L. Kalinowski,et al.  Nitric Oxide-Dependent Pathways as Critical Factors in the Consequences and Recovery after Brain Ischemic Hypoxia , 2021, Biomolecules.

[22]  B. Morris,et al.  Differential Effects of Toll-Like Receptor Activation and Differential Mediation by MAP Kinases of Immune Responses in Microglial Cells , 2021, Cellular and Molecular Neurobiology.

[23]  Shaoyun Cheng,et al.  TIM-3: An update on immunotherapy. , 2021, International immunopharmacology.

[24]  K. Marks,et al.  Toll-like Receptor 2 in Autoimmune Inflammation , 2021, Immune network.

[25]  D. Stolz,et al.  Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke. , 2021, Immunity.

[26]  P. Lei,et al.  Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications , 2021, Medicinal research reviews.

[27]  Fen-fang Hong,et al.  The Roles of Nitric Oxide Synthase/Nitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches , 2021, International journal of molecular sciences.

[28]  T. G. Singh,et al.  Sirtuin Acetylation and Deacetylation: a Complex Paradigm in Neurodegenerative Disease , 2021, Molecular Neurobiology.

[29]  T. G. Singh,et al.  Stressed mitochondria: a target to intrude alzheimer's disease. , 2021, Mitochondrion.

[30]  T. G. Singh,et al.  Mechanistic insight on the role of leukotriene receptors in ischemic–reperfusion injury , 2021, Pharmacological Reports.

[31]  K. Aonuma,et al.  Programmed Death-Ligand 2 Deficiency Exacerbates Experimental Autoimmune Myocarditis in Mice , 2021, International journal of molecular sciences.

[32]  Abdullah Al Mamun,et al.  Phosphorylation of Microglial IRF5 and IRF4 by IRAK4 Regulates Inflammatory Responses to Ischemia , 2021, Cells.

[33]  Yujia Yuan,et al.  Regulatory T cells in ischemic stroke , 2021, Acta Pharmacologica Sinica.

[34]  T. G. Singh,et al.  CREB: A Multifaceted Target for Alzheimer's Disease. , 2021, Current Alzheimer research.

[35]  T. G. Singh,et al.  Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases. , 2020, Life sciences.

[36]  E. Ropelle,et al.  Role of TLR4 in physical exercise and cardiovascular diseases. , 2020, Cytokine.

[37]  H. Anders,et al.  Neutrophils and Neutrophil Extracellular Traps Regulate Immune Responses in Health and Disease , 2020, Cells.

[38]  T. G. Singh,et al.  Pharmacological postconditioning: a molecular aspect in ischemic injury , 2020, The Journal of pharmacy and pharmacology.

[39]  X-B Dong,et al.  Non-coding RNAs in Ischemic Stroke: Roles in the Neuroinflammation and Cell Death , 2020, Neurotoxicity Research.

[40]  C. Burger,et al.  The Role of PD-1 in Acute and Chronic Infection , 2020, Frontiers in Immunology.

[41]  J. Simard,et al.  HMGB1 is a Potential Mediator of Astrocytic TLR4 Signaling Activation following Acute and Chronic Focal Cerebral Ischemia , 2020, Neurology research international.

[42]  L. McCullough,et al.  Sex differences in T cell immune responses, gut permeability and outcome after ischemic stroke in aged mice , 2020, Brain, Behavior, and Immunity.

[43]  T. Langenhan.  Adhesion G protein-coupled receptors-Candidate metabotropic mechanosensors and novel drug targets. , 2020, Basic & clinical pharmacology & toxicology.

[44]  L. McCullough,et al.  Microglial IRF5-IRF4 regulatory axis regulates neuroinflammation after cerebral ischemia and impacts stroke outcomes , 2019, Proceedings of the National Academy of Sciences.

[45]  H. Enocsson,et al.  Neutrophil Extracellular Traps (NETs) in the Cerebrospinal Fluid Samples from Children and Adults with Central Nervous System Infections , 2019, Cells.

[46]  M. Bijak,et al.  Plasma MicroRNA as a novel diagnostic. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[47]  G. Rosenberg,et al.  Neuroinflammation: friend and foe for ischemic stroke , 2019, Journal of Neuroinflammation.

[48]  Shizhong Zhang,et al.  Emerging therapeutic targets associated with the immune system in patients with intracerebral haemorrhage (ICH): From mechanisms to translation , 2019, EBioMedicine.

[49]  P. Coppo,et al.  An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura , 2019, Expert review of hematology.

[50]  Yuanfa Tao,et al.  Hyperforin Promotes Post-stroke Neuroangiogenesis via Astrocytic IL-6-Mediated Negative Immune Regulation in the Ischemic Brain , 2019, Front. Cell. Neurosci..

[51]  A. Mashaghi,et al.  Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling , 2019, Scientific Reports.

[52]  Yi Shi,et al.  RETRACTED ARTICLE: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus , 2019, Scientific Reports.

[53]  Yuxian He,et al.  Lipopolysaccharide mediates time‐dependent macrophage M1/M2 polarization through the Tim‐3/Galectin‐9 signalling pathway , 2019, Experimental cell research.

[54]  J. Kriz,et al.  Tlr2 Deficiency is Associated with Enhanced Elements of Neuronal Repair and Caspase 3 Activation Following Brain Ischemia , 2019, Scientific Reports.

[55]  Xin Zhang,et al.  P2Y12 regulates microglia activation and excitatory synaptic transmission in spinal lamina II neurons during neuropathic pain in rodents , 2019, Cell Death & Disease.

[56]  R. Cooney,et al.  Sparstolonin B: A Unique Anti-Inflammatory Agent. , 2019, Shock.

[57]  A. Yoshimura,et al.  Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery , 2019, Nature.

[58]  V. Brunton,et al.  The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype , 2018, Science Advances.

[59]  V. Yong,et al.  Efficacy of Minocycline in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Rodent and Clinical Studies , 2018, Front. Neurol..

[60]  Tianlong Liu,et al.  Z‐Guggulsterone attenuates astrocytes‐mediated neuroinflammation after ischemia by inhibiting toll‐like receptor 4 pathway , 2018, Journal of neurochemistry.

[61]  Weifeng Yu,et al.  Cancer Exacerbates Ischemic Brain Injury Via Nrp1 (Neuropilin 1)-Mediated Accumulation of Regulatory T Cells Within the Tumor , 2018, Stroke.

[62]  J. King,et al.  Detection of T. urartu Introgressions in Wheat and Development of a Panel of Interspecific Introgression Lines , 2018, Front. Plant Sci..

[63]  L. Schlichter,et al.  Microglia Responses to Pro-inflammatory Stimuli (LPS, IFNγ+TNFα) and Reprogramming by Resolving Cytokines (IL-4, IL-10) , 2018, Front. Cell. Neurosci..

[64]  Junmei Chen,et al.  Inflammation, von Willebrand factor, and ADAMTS13. , 2018, Blood.

[65]  M. Abdelsaid,et al.  Inhibition of Toll-Like Receptor-4 (TLR-4) Improves Neurobehavioral Outcomes After Acute Ischemic Stroke in Diabetic Rats: Possible Role of Vascular Endothelial TLR-4 , 2018, Molecular Neurobiology.

[66]  A. Alexandrov,et al.  Minocycline for acute stroke treatment: a systematic review and meta-analysis of randomized clinical trials , 2018, Journal of Neurology.

[67]  C. Reis,et al.  The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets , 2018, Cell transplantation.

[68]  F. Hua,et al.  Neuroprotection Against Hypoxic/Ischemic Injury: δ-Opioid Receptors and BDNF-TrkB Pathway , 2018, Cellular Physiology and Biochemistry.

[69]  Lili Yu,et al.  The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure , 2018, Mediators of inflammation.

[70]  Sichun Gu,et al.  Early Selective Serotonin Reuptake Inhibitors for Recovery after Stroke: A Meta-Analysis and Trial Sequential Analysis. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[71]  J. Aronowski,et al.  Protective Effects of Autologous Bone Marrow Mononuclear Cells After Administering t-PA in an Embolic Stroke Model , 2018, Translational Stroke Research.

[72]  J. Klopfenstein,et al.  Mesenchymal Stem Cell Treatment Prevents Post-Stroke Dysregulation of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases , 2017, Cellular Physiology and Biochemistry.

[73]  J. Liao,et al.  ROCK as a therapeutic target for ischemic stroke , 2017, Expert review of neurotherapeutics.

[74]  B. Harvey,et al.  Role of microglia in ischemic focal stroke and recovery: focus on Toll-like receptors , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[75]  Simon C Watkins,et al.  C‐C Chemokine Receptor Type 5 (CCR5)‐Mediated Docking of Transferred Tregs Protects Against Early Blood‐Brain Barrier Disruption After Stroke , 2017, Journal of the American Heart Association.

[76]  N. Plesnila,et al.  The choroid plexus is a key cerebral invasion route for T cells after stroke , 2017, Acta Neuropathologica.

[77]  Weifeng Yu,et al.  Regulatory T cells ameliorate tissue plasminogen activator-induced brain haemorrhage after stroke , 2017, Brain : a journal of neurology.

[78]  J. Hao,et al.  MicroRNA-132 attenuates neurobehavioral and neuropathological changes associated with intracerebral hemorrhage in mice , 2017, Neurochemistry International.

[79]  Gang Chen,et al.  The role of nitric oxide in stroke , 2017, Medical gas research.

[80]  Wei Wu,et al.  Thrombin-induced, TNFR-dependent miR-181c downregulation promotes MLL1 and NF-κB target gene expression in human microglia , 2017, Journal of Neuroinflammation.

[81]  G. Cardona-Gómez,et al.  The Role of Astrocytes in Neuroprotection after Brain Stroke: Potential in Cell Therapy , 2017, Front. Mol. Neurosci..

[82]  Fudong Liu,et al.  Regulation of microglial activation in stroke , 2017, Acta Pharmacologica Sinica.

[83]  H. Hara,et al.  Toll-like receptor 4 inhibitor protects against retinal ganglion cell damage induced by optic nerve crush in mice. , 2017, Journal of pharmacological sciences.

[84]  A. ElAli,et al.  Complex Roles of Microglial Cells in Ischemic Stroke Pathobiology: New Insights and Future Directions , 2017, International journal of molecular sciences.

[85]  Chung Y. Hsu,et al.  A Crucial Role of CXCL14 for Promoting Regulatory T Cells Activation in Stroke , 2017, Theranostics.

[86]  N. Beerenwinkel,et al.  αV-class integrins exert dual roles on α5β1 integrins to strengthen adhesion to fibronectin , 2017, Nature Communications.

[87]  M. Demirbilek,et al.  Plasma levels of vitamin B12, epidermal growth factor and tumor necrosis factor alpha in patients with alzheimer dementia , 2016 .

[88]  E. Erba,et al.  Macrophages are essential for maintaining a M2 protective response early after ischemic brain injury , 2016, Neurobiology of Disease.

[89]  Yue Zhang,et al.  Innate recognition of microbial-derived signals in immunity and inflammation , 2016, Science China Life Sciences.

[90]  C. Meisel,et al.  Stroke induces specific alteration of T memory compartment controlling auto-reactive CNS antigen-specific T cell responses , 2016, Journal of the Neurological Sciences.

[91]  C. Gahmberg,et al.  LFA-1 integrin antibodies inhibit leukocyte α4β1-mediated adhesion by intracellular signaling. , 2016, Blood.

[92]  Yutian Li,et al.  MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response , 2016, Shock.

[93]  D. Gill,et al.  Clinical Trials of Immunomodulation in Ischemic Stroke , 2016, Neurotherapeutics.

[94]  M. Han,et al.  Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation , 2016, Drugs.

[95]  R. Peach,et al.  Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P1) and receptor‐5 (S1P5) agonist with autoimmune disease‐modifying activity , 2016, British journal of pharmacology.

[96]  G. Freeman,et al.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family. , 2016, Immunity.

[97]  G. Katona,et al.  Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke , 2016, Nature Communications.

[98]  Eric G. Pamer,et al.  Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδT cells , 2016, Nature Medicine.

[99]  Á. Chamorro,et al.  Immature monocytes recruited to the ischemic mouse brain differentiate into macrophages with features of alternative activation , 2016, Brain, Behavior, and Immunity.

[100]  J. Simard,et al.  Treatment of Edema Associated With Intracerebral Hemorrhage , 2016, Current Treatment Options in Neurology.

[101]  Y. Cui,et al.  Neuroprotective Effects of Resatorvid Against Traumatic Brain Injury in Rat: Involvement of Neuronal Autophagy and TLR4 Signaling Pathway , 2016, Cellular and Molecular Neurobiology.

[102]  Xiaotang Ma,et al.  MicroRNA‐155 Regulates ROS Production, NO Generation, Apoptosis and Multiple Functions of Human Brain Microvessel Endothelial Cells Under Physiological and Pathological Conditions , 2015, Journal of cellular biochemistry.

[103]  Xiaoguang Lei,et al.  Using Small Molecules to Dissect Non‐apoptotic Programmed Cell Death: Necroptosis, Ferroptosis, and Pyroptosis , 2015, Chembiochem : a European journal of chemical biology.

[104]  Chih-Lung Lin,et al.  Arctigenin, a Potent Ingredient of Arctium lappa L., Induces Endothelial Nitric Oxide Synthase and Attenuates Subarachnoid Hemorrhage-Induced Vasospasm through PI3K/Akt Pathway in a Rat Model , 2015, BioMed research international.

[105]  I. Dumitriu.  The life (and death) of CD4+CD28null T cells in inflammatory diseases , 2015, Immunology.

[106]  Xingshun Xu,et al.  MicroRNA let-7c-5p protects against cerebral ischemia injury via mechanisms involving the inhibition of microglia activation , 2015, Brain, Behavior, and Immunity.

[107]  M. Pekny,et al.  Heterogeneity of Notch signaling in astrocytes and the effects of GFAP and vimentin deficiency , 2015, Journal of neurochemistry.

[108]  A. Vandenbark,et al.  PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System Inflammation , 2015, Stroke.

[109]  Ji-xian Wang,et al.  Activated regulatory T cell regulates neural stem cell proliferation in the subventricular zone of normal and ischemic mouse brain through interleukin 10 , 2015, Front. Cell. Neurosci..

[110]  R. Leak,et al.  Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral Ischemia , 2015, Stroke.

[111]  Feng Yan,et al.  Neuroprotective effect of microRNA-99a against focal cerebral ischemia–reperfusion injury in mice , 2015, Journal of the Neurological Sciences.

[112]  N. Plesnila,et al.  Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia , 2015, Science Translational Medicine.

[113]  A. Warnatsch,et al.  Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis , 2015, Science.

[114]  A. Abdel-Hamid,et al.  Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients , 2015, Archives of Virology.

[115]  Bangqing Yuan,et al.  MicroRNA-223 regulates inflammation and brain injury via feedback to NLRP3 inflammasome after intracerebral hemorrhage. , 2015, Molecular immunology.

[116]  K. Tsai,et al.  Memantine Attenuates Delayed Vasospasm after Experimental Subarachnoid Hemorrhage via Modulating Endothelial Nitric Oxide Synthase , 2015, International journal of molecular sciences.

[117]  X. Zheng.  ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. , 2015, Annual review of medicine.

[118]  R. Leak,et al.  Microglial and macrophage polarization—new prospects for brain repair , 2015, Nature Reviews Neurology.

[119]  W. Le,et al.  Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases , 2016, Molecular Neurobiology.

[120]  Huiqing Liu,et al.  Tetramethylpyrazine Analogue CXC195 Ameliorates Cerebral Ischemia–reperfusion Injury by Regulating Endothelial Nitric Oxide Synthase Phosphorylation Via PI3K/Akt Signaling , 2015, Neurochemical Research.

[121]  H. Heinze,et al.  Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke , 2015, Acta Neuropathologica.

[122]  B. Devi,et al.  Correlation between plasma total nitric oxide levels and cerebral vasospasm and clinical outcome in patients with aneurysmal subarachnoid hemorrhage in Indian population , 2014, Journal of neurosciences in rural practice.

[123]  Y. E. Chen,et al.  Non-coding RNAs in cerebral endothelial pathophysiology: Emerging roles in stroke , 2014, Neurochemistry International.

[124]  Sarah Spiegel,et al.  Export of sphingosine-1-phosphate and cancer progression , 2014, Journal of Lipid Research.

[125]  H. Wiendl,et al.  VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells , 2014, Journal of Neuroimmunology.

[126]  X. Chen,et al.  Calycosin-7-O-β-D-glucoside regulates nitric oxide /caveolin-1/matrix metalloproteinases pathway and protects blood-brain barrier integrity in experimental cerebral ischemia-reperfusion injury. , 2014, Journal of ethnopharmacology.

[127]  G. Pedraza-Alva,et al.  microRNAs: key triggers of neuronal cell fate , 2014, Front. Cell. Neurosci..

[128]  J. Simpkins,et al.  mTOR Signaling Inhibition Modulates Macrophage/Microglia-Mediated Neuroinflammation and Secondary Injury via Regulatory T Cells after Focal Ischemia , 2014, The Journal of Immunology.

[129]  J. Y. Kim,et al.  Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets. , 2014, Current medicinal chemistry.

[130]  Sunghee Cho,et al.  Role of Spleen-Derived Monocytes/Macrophages in Acute Ischemic Brain Injury , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[131]  A. Nimmerjahn,et al.  Stepwise Recruitment of Transcellular and Paracellular Pathways Underlies Blood-Brain Barrier Breakdown in Stroke , 2014, Neuron.

[132]  Marco Prinz,et al.  Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease , 2014, Nature Reviews Neuroscience.

[133]  R. Leak,et al.  Molecular dialogs between the ischemic brain and the peripheral immune system: Dualistic roles in injury and repair , 2014, Progress in Neurobiology.

[134]  S. Reddy,et al.  Reactive oxygen species in inflammation and tissue injury. , 2014, Antioxidants & redox signaling.

[135]  W. Schäbitz,et al.  Bone marrow-derived mononuclear cells do not exert acute neuroprotection after stroke in spontaneously hypertensive rats , 2014, Front. Cell. Neurosci..

[136]  K. Furie,et al.  Selective ROCK2 inhibition in focal cerebral ischemia , 2013, Annals of clinical and translational neurology.

[137]  Y. Wang,et al.  MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain , 2013, Gene Therapy.

[138]  S. Devaraj,et al.  Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. , 2014, The Journal of clinical endocrinology and metabolism.

[139]  Jie Jia,et al.  Prior exposure to enriched environment reduces nitric oxide synthase after transient MCAO in rats. , 2013, Neurotoxicology.

[140]  Youyong Li,et al.  Advances in the development of Rho-associated protein kinase (ROCK) inhibitors. , 2013, Drug discovery today.

[141]  Chao Jiang,et al.  Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis , 2013, Brain, Behavior, and Immunity.

[142]  L. Sansing,et al.  Microglial Responses after Ischemic Stroke and Intracerebral Hemorrhage , 2013, Clinical & developmental immunology.

[143]  C. Théry,et al.  Phagocytosis executes delayed neuronal death after focal brain ischemia , 2013, Proceedings of the National Academy of Sciences.

[144]  A. Vandenbark,et al.  PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1 , 2013, Journal of Neuroinflammation.

[145]  A. Basu,et al.  A friend in need may not be a friend indeed: role of microglia in neurodegenerative diseases. , 2013, CNS & neurological disorders drug targets.

[146]  E. Ling,et al.  Glutamate receptors in microglia. , 2013, CNS & neurological disorders drug targets.

[147]  J. Roh,et al.  Effects of celecoxib on hematoma and edema volumes in primary intracerebral hemorrhage: a multicenter randomized controlled trial , 2013, European journal of neurology.

[148]  P. Gressens,et al.  Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro , 2013, Brain, Behavior, and Immunity.

[149]  W. Aird,et al.  Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. , 2013, Blood.

[150]  Xuesong Tian,et al.  δ-Opioid Receptor Activation Rescues the Functional TrkB Receptor and Protects the Brain from Ischemia-Reperfusion Injury in the Rat , 2013, PloS one.

[151]  P. Ge,et al.  TLR2 and TLR4 in the Brain Injury Caused by Cerebral Ischemia and Reperfusion , 2013, Mediators of inflammation.

[152]  F. Zhang,et al.  Adoptive regulatory T‐cell therapy protects against cerebral ischemia , 2013, Annals of neurology.

[153]  Shuvomoy Banerjee,et al.  The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8 , 2013, PLoS pathogens.

[154]  Jie Liu,et al.  Normobaric hyperoxia combined with minocycline provides greater neuroprotection than either alone in transient focal cerebral ischemia , 2013, Experimental Neurology.

[155]  P. Jakob,et al.  Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. , 2013, Blood.

[156]  M. Dontenwill,et al.  Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors , 2013, Cancers.

[157]  G. Royl,et al.  Regulatory T Cells Accumulate and Proliferate in the Ischemic Hemisphere for up to 30 Days after MCAO , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[158]  F. Kirkham,et al.  Role of reduced ADAMTS13 in arterial ischemic stroke: A Pediatric Cohort Study , 2013, Annals of neurology.

[159]  H. Weiner,et al.  MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS , 2013, Glia.

[160]  M. Endres,et al.  The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury , 2012, Acta Neuropathologica.

[161]  P. Koh.  Ferulic acid modulates nitric oxide synthase expression in focal cerebral ischemia , 2012, Laboratory animal research.

[162]  H. Hartung,et al.  Macrophages prevent hemorrhagic infarct transformation in murine stroke models , 2012, Annals of neurology.

[163]  Yan Fang,et al.  Autologous transplantation of adipose-derived mesenchymal stem cells attenuates cerebral ischemia and reperfusion injury through suppressing apoptosis and inducible nitric oxide synthase. , 2012, International journal of molecular medicine.

[164]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[165]  P. Mannucci,et al.  Advantages and limits of ADAMTS13 testing in the prognostic assessment of thrombotic thrombocytopenic purpura. , 2012, Presse medicale.

[166]  Yihua Zhang,et al.  (S)-ZJM-289, a nitric oxide-releasing derivative of 3-n-butylphthalide, protects against ischemic neuronal injury by attenuating mitochondrial dysfunction and associated cell death , 2012, Neurochemistry International.

[167]  S. Fumagalli,et al.  Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice , 2011, Journal of Neuroinflammation.

[168]  K. Gomes,et al.  ADAMTS13 and von Willebrand factor assessment before and after kidney transplantation. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[169]  Y. Tsai,et al.  Ligustilide prevents LPS-induced iNOS expression in RAW 264.7 macrophages by preventing ROS production and down-regulating the MAPK, NF-κB and AP-1 signaling pathways. , 2011, International immunopharmacology.

[170]  P. Hurn,et al.  Programmed Death-1 Pathway Limits Central Nervous System Inflammation and Neurologic Deficits in Murine Experimental Stroke , 2011, Stroke.

[171]  Y. Liu,et al.  Increased T cell Immunoglobulin and Mucin Domain 3 Positively Correlate with Systemic IL-17 and TNF-α Level in the Acute Phase of Ischemic Stroke , 2011, Journal of Clinical Immunology.

[172]  D. Hess,et al.  Minocycline Development for Acute Ischemic Stroke , 2011, Translational Stroke Research.

[173]  G. Hirokawa,et al.  Plasma miR-124 as a biomarker for cerebral infarction. , 2011, Biomedical research.

[174]  C. Sommer,et al.  Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. , 2011, Brain : a journal of neurology.

[175]  R. Macdonald,et al.  Simvastatin Re-Couples Dysfunctional Endothelial Nitric Oxide Synthase in Experimental Subarachnoid Hemorrhage , 2011, PloS one.

[176]  F. Chollet,et al.  Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial , 2011, The Lancet Neurology.

[177]  Chun-Hua Wang,et al.  Baicalin Inhibits TLR2/4 Signaling Pathway in Rat Brain Following Permanent Cerebral Ischemia , 2011, Inflammation.

[178]  Huaxi Xu,et al.  APP processing in Alzheimer's disease , 2011, Molecular Brain.

[179]  D. Greaves,et al.  Chemerin Contributes to Inflammation by Promoting Macrophage Adhesion to VCAM-1 and Fibronectin through Clustering of VLA-4 and VLA-5 , 2010, The Journal of Immunology.

[180]  C. Hsieh,et al.  Ferulic acid inhibits nitric oxide-induced apoptosis by enhancing GABAB1 receptor expression in transient focal cerebral ischemia in rats , 2010, Acta Pharmacologica Sinica.

[181]  Julie A Saugstad,et al.  MicroRNAs as Effectors of Brain Function with Roles in Ischemia and Injury, Neuroprotection, and Neurodegeneration , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[182]  M. Höltje,et al.  C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts , 2010, Journal of Cell Science.

[183]  H. Wiendl,et al.  Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. , 2010, Blood.

[184]  Chun-Hua Wang,et al.  Spatio-Temporal Distribution of Inflammatory Reaction and Expression of TLR2/4 Signaling Pathway in Rat Brain Following Permanent Focal Cerebral Ischemia , 2010, Neurochemical Research.

[185]  T. Möller,et al.  Microglia in ischemic brain injury. , 2010, Future neurology.

[186]  S. Akira,et al.  Microsomal prostaglandin E synthase‐1 and cyclooxygenase‐2 are both required for ischaemic excitotoxicity , 2010, British journal of pharmacology.

[187]  Sarah Baird,et al.  Cash or Condition? Evidence from a Cash Transfer Experiment , 2010 .

[188]  Teng-Nan Lin,et al.  Anti-apoptotic Actions of PPAR-γ Against Ischemic Stroke , 2010, Molecular Neurobiology.

[189]  Roger Strong,et al.  Autologous Bone Marrow Mononuclear Cells Enhance Recovery after Acute Ischemic Stroke in Young and Middle-Aged Rats , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[190]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[191]  A. Chauhan,et al.  von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. , 2009, Blood.

[192]  Xiaomei Wang,et al.  Human Pregnancy Up-Regulates Tim-3 in Innate Immune Cells for Systemic Immunity1 , 2009, The Journal of Immunology.

[193]  K. Liu,et al.  Normobaric hyperoxia attenuates early blood–brain barrier disruption by inhibiting MMP‐9‐mediated occludin degradation in focal cerebral ischemia , 2009, Journal of neurochemistry.

[194]  T. G. Singh,et al.  Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine (H1) receptor activation-linked mechanism , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[195]  Karin E. Sandoval,et al.  Blood-brain barrier tight junction permeability and ischemic stroke , 2008, Neurobiology of Disease.

[196]  M. Mattson,et al.  Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenal , 2008, Experimental Neurology.

[197]  Y. Ou,et al.  Opioids modulate post-ischemic progression in a rat model of stroke , 2008, Neurochemistry International.

[198]  B. Fiebich,et al.  Cyclooxygenase inhibition in ischemic brain injury. , 2008, Current pharmaceutical design.

[199]  J. Yi,et al.  Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. , 2008, Frontiers in bioscience : a journal and virtual library.

[200]  T. Kossmann,et al.  Modulation of immune response by head injury. , 2007, Injury.

[201]  R. Kauppinen,et al.  Proliferating Resident Microglia after Focal Cerebral Ischaemia in Mice , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[202]  David E. Anderson,et al.  Promotion of Tissue Inflammation by the Immune Receptor Tim-3 Expressed on Innate Immune Cells , 2007, Science.

[203]  T. Mayadas,et al.  Essential role for Rap1 GTPase and its guanine exchange factor CalDAG-GEFI in LFA-1 but not VLA-4 integrin mediated human T-cell adhesion. , 2007, Blood.

[204]  C. Fuchs,et al.  Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[205]  J. Kalbfleisch,et al.  Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion , 2007, Journal of Neuroimmunology.

[206]  R. Nitsch,et al.  Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia , 2007, Journal of Neuroimmunology.

[207]  D. Granger,et al.  The Evolving Paradigm for Blood Cell‐Endothelial Cell Interactions in the Cerebral Microcirculation , 2007, Microcirculation.

[208]  M. Heinonen,et al.  Anti-Inflammatory Effects of Flavonoids: Genistein, Kaempferol, Quercetin, and Daidzein Inhibit STAT-1 and NF-κB Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit only NF-κB Activation along with Their Inhibitory Effect on iNOS Expression and NO Production in Activated , 2007, Mediators of inflammation.

[209]  E. Mackenzie,et al.  Long-term alterations in μ, δ and κ opioidergic receptors following middle cerebral artery occlusion in mice , 2007, Acta Neuropathologica.

[210]  T. Hla,et al.  Induction of Vascular Permeability by the Sphingosine-1-Phosphate Receptor–2 (S1P2R) and its Downstream Effectors ROCK and PTEN , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[211]  T. Herdegen,et al.  PPAR-γ: therapeutic target for ischemic stroke , 2007 .

[212]  R. Macdonald,et al.  Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution , 2007, Nature Clinical Practice Neurology.

[213]  Jeffrey F. Thompson,et al.  Matrix Metalloproteinase-Mediated Disruption of Tight Junction Proteins in Cerebral Vessels is Reversed by Synthetic Matrix Metalloproteinase Inhibitor in Focal Ischemia in Rat , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[214]  C. Carman,et al.  Structural basis of integrin regulation and signaling. , 2007, Annual review of immunology.

[215]  C. Farina,et al.  Astrocytes are active players in cerebral innate immunity. , 2007, Trends in immunology.

[216]  E. Oldfield,et al.  Analysis of nitric oxide (NO) in cerebral vasospasm after aneursymal bleeding. , 2007, Reviews on recent clinical trials.

[217]  E. Simpson.  A historical perspective on immunological privilege , 2006, Immunological reviews.

[218]  Z. Zuo,et al.  Opioid Preconditioning Induces Opioid Receptor-Dependent Delayed Neuroprotection Against Ischemia in Rats , 2006, Journal of neuropathology and experimental neurology.

[219]  R. Tamargo,et al.  Inflammation in stroke and focal cerebral ischemia. , 2006, Surgical neurology.

[220]  Xiongfei Xu,et al.  Nicotiflorin reduces cerebral ischemic damage and upregulates endothelial nitric oxide synthase in primarily cultured rat cerebral blood vessel endothelial cells. , 2006, Journal of ethnopharmacology.

[221]  Ian Parker,et al.  Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo , 2006, Nature chemical biology.

[222]  T. Kielian.  Toll‐like receptors in central nervous system glial inflammation and homeostasis , 2006, Journal of neuroscience research.

[223]  G. Landreth,et al.  Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia , 2005, Neuroscience.

[224]  E. Ringelstein,et al.  Predominant phagocytic activity of resident microglia over hematogenous macrophages following transient focal cerebral ischemia: An investigation using green fluorescent protein transgenic bone marrow chimeric mice , 2005, Experimental Neurology.

[225]  S. Hirai,et al.  Effects of fasudil in acute ischemic stroke: Results of a prospective placebo-controlled double-blind trial , 2005, Journal of the Neurological Sciences.

[226]  B. Maier,et al.  Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study. , 2005, Journal of neurotrauma.

[227]  S. Tzeng,et al.  Prostaglandins and cyclooxygenases in glial cells during brain inflammation. , 2005, Current drug targets. Inflammation and allergy.

[228]  Ying Xia,et al.  Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. , 2005, The Journal of biological chemistry.

[229]  C. Ballantyne,et al.  Contributions of LFA-1 and Mac-1 to brain injury and microvascular dysfunction induced by transient middle cerebral artery occlusion. , 2004, American journal of physiology. Heart and circulatory physiology.

[230]  J. Dambrosia,et al.  Elevated pro-inflammatory CD4+CD28− lymphocytes and stroke recurrence and death , 2004, Neurology.

[231]  D. Hess,et al.  SDF‐1 (CXCL12) Is Upregulated in the Ischemic Penumbra Following Stroke: Association with Bone Marrow Cell Homing to Injury , 2004, Journal of neuropathology and experimental neurology.

[232]  R. McCarron,et al.  Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[233]  U. Dirnagl,et al.  Stroke-induced Immunodeficiency Promotes Spontaneous Bacterial Infections and Is Mediated by Sympathetic Activation Reversal by Poststroke T Helper Cell Type 1–like Immunostimulation , 2003, The Journal of experimental medicine.

[234]  P. Loke,et al.  PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[235]  J. Mocco,et al.  HuEP5C7 as a Humanized Monoclonal Anti-E/P-Selectin Neurovascular Protective Strategy in a Blinded Placebo-Controlled Trial of Nonhuman Primate Stroke , 2002, Circulation research.

[236]  R. McCarron,et al.  Induction of Mucosal Tolerance to E-Selectin Prevents Ischemic and Hemorrhagic Stroke in Spontaneously Hypertensive Genetically Stroke-Prone Rats , 2002, Stroke.

[237]  Michael D. Davis,et al.  The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors* , 2002, The Journal of Biological Chemistry.

[238]  N. Sims,et al.  Mitochondrial contributions to tissue damage in stroke , 2002, Neurochemistry International.

[239]  J. Orozco,et al.  Protective effects of inhibiting both blood and vascular selectins after stroke and reperfusion , 2002, Neurological research.

[240]  E. Benveniste,et al.  Immune function of astrocytes , 2001, Glia.

[241]  M. Yenari,et al.  L-selectin inhibition does not reduce injury in a rabbit model of transient focal cerebral ischemia , 2001, Neurological research.

[242]  K. Herkner,et al.  Heat shock protein-70 repairs proximal tubule structure after renal ischemia. , 2000, Kidney international.

[243]  K. Abe,et al.  Anti-P-selectin antibody attenuates rat brain ischemic injury , 1999, Neuroscience Letters.

[244]  Michael Chopp,et al.  P-selectin antibody reduces hemorrhage and infarct volume resulting from MCA occlusion in the rat , 1998, Journal of the Neurological Sciences.

[245]  M. Bednar,et al.  Humanized anti-L-selectin monoclonal antibody DREG200 therapy in acute thromboembolic stroke. , 1998, Neurological research.

[246]  E. Connolly,et al.  Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. , 1997, Circulation research.

[247]  E. Plow,et al.  Fibrinogen Is a Ligand for Integrin α5β1 on Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[248]  M. Chopp,et al.  E-Selectin in Focal Cerebral Ischemia and Reperfusion in the Rat , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[249]  B. Brüne,et al.  Heat shock proteins and macrophage resistance to the toxic effects of nitric oxide. , 1996, The Biochemical journal.

[250]  K. Seibert,et al.  Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[251]  S. Albelda,et al.  Integrins and other cell adhesion molecules , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.